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ABSTRACT
Background: Eurycomanon an active substance from the roots of the pasak bumi used to treat cancer. The
compounds present in very small amounts that need to be optimized solvent.
Objective: The purpose of this study is to optimize the extraction method of eurycoma or pasak bumi roors
using simplex lattice design.
]Iethods: One gram of root powder macerated pasak bumi each in 5 ml of solvent, with 3 diff'erent solr'ents.
ramely: water, ethanol 50 o/o,70 %o and 96 oh ethanol. Maceration levels determined by HPLC u'ith lased
srlica gel 60 F25a and phase motion methanol: chloroform (8: 2), with a maximum length of 30i nm.
Outcome Measured: Levels obtained from the laboratory scale and then put into the equation Simplex
-attice Design (SLD) by incorporating response levels obtained, it can be calculated price coefsien ab and
.:,. Value of Y (response) for each variation mixtures A and B is calculated, so that the profile can be
::scribed.
: From the results obtained, the optimum composition of the fluid eurycomanom quote from the roots
the earth peg in a semi industrial scale is I00 % water conformed to the equation, simplex lattice design
the equation Y :71693.153 [A] + 7766.246lBl+ 7721.57 [A] [B].
: Prediction results obtained between response levels on eurycomanon laboratory scale with
analysis by t test showed differences are not significant, so the simplex lattice design equations that
be obtained be used to predict the optimum ratio of ethanol-water,
: Root Pasak Bumi (Eurycoma longifolia, Jack), Eurycomanon, Simplex Lattice Design
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INTRODUCTION
Cancer is one of the major diseases
causing death. In 2010, deaths from cancer in
the United States reached 25 o/o increased I o/o
over the last 10 tahn (Brooks, 20ll). In
Indonesia, ranked sixth cause of cancer death( 1-indarbumi and Mangunkusumo, 2002).one
plant efficacious as anticancer there was the
root of the pasak bumi. However, if the plant
is consumed in excess can be nefrotosik
(Chan and Choo, 2002). This indicates the
nature of the active compounds in the plant
roots pasak bumi not only selectively against
cancer cells (Bhat and Karim). Extract active
compounds need to be very high because of
its potential as an anticancer.
Plant roots contain several pasak bumi
efficacious anticancer compounds.
Compounds contained in the roots of the 9 -
methoxycanthin dominant - 6one (Rosli et al.,
2009), eurycomalacton (Chan et al., 1992),
squalene (Morita et al., 1993), as well as
eurycomanon (Ang et dl., 2002). These
compounds have antimalarial effects (Kuo et
al., 2004), antitumor (Nurhanan et a1., 2005),
and chemopreventive (Conscience, et al.,
2009). This compound is acidic so it can
interact the premises chitosan (Kumar et a1.,
2005) so that the formula will be obtained
chitosan nanoparticle - targeting compounds
of the roots of the pasak bumi antrcancer
anticancer properties that have a high
selectivity. Eurycomanon levels in plants by
only 0.5%. Based on these two needs to
optimize extraction by solvent that produces
most of the levels, Ethanol and Water is
commonly used as solvent extract active
compounds in the extracts of natural products
industry. Comparison of ethanol and water
need to be sought to determine the extract
eurycomanon maximum yield.
METHODS
Making a series of standar dsolution
Standard eurycomanon much as 125
mg, dissolved in distilled water : methanol
(1:1) to 25 ml (mother liquor : 5 mg / ml)
made a series of standard solution of 5mg/m1;
4m/m|. 3mg/ml; 2mglm|, lmg/ml. Standard
solution is then injected into the HPLC
column. silica gel 60 Fzsa with a mobile phase
oimethanol : chloroform (8:2). The next area
is calculated and linear regression equation to
be used as a standard curve.
Optimization of fluids with the method
simplex lattice design
Weighed 1.0 grams of powdered root
pasak bumi, as much as 3 times and enter
separately into flacon. Powder used in this
study advance lipid extract with petroleum
ether. Furthermore, each flacon plus different
solvents are: water, 50 % ethanol and 96 o/o
ethanol as much as 5 ml and macerated for 20
hours while often shaken, filtered, then each
matched to the volume of 5 ml in a pint flask.
The drawback with the solvent flowed
through the dregs to 5 ml. Parameter
optimization results is the level of the active
substance is eurycomanon. Determination of
the active compounds was done by HPLC
with a C - 18 stationary phase and mobile
phase pH buffer - acetonitrile and comparison
optimized first (Choo and Chan, 2002).
Eurycomanon levels obtained from
each solvent and then analyzed using simplex
lattice design method to determine the
composition of the ethanol - water solvent
optimum eurycomanon to sum up the pasak
bumi roots. Parameter optrmization results is
the level of the active substance is
eurycomanon. Determination of the active
compounds was done by HPLC with a C - 18
stationary phase and mobile phase pH buffer -
acetonitrile and comparison optimized first
(Choo and Chan, 2002).
RESULTS AND DISCUSSION
Preparation of the main ingredients
The main materials used in this stud1
are the root of the pasak bumi Kahmantan. In
a subsequent sample processing used three
types of solvents or liquids that extract for
laboratory scale is water, 50o/o ethanol and
96oh ethanol, while for semi industrial scale
using 50% ethanol, l)oh ethanol and 960,
ethanol by maceration method. Prior to
extract eurycomanon in the sample, first
performed lipid extraction samples with
petroleum ether. This is to sum up the fat and
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CONCLUSION
Based on the calculation method of
simplex lattice design the most optimal
solvent to sum up the roots of the pasak bumi
eurycomanon is solvent water 100 % .
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